<SEC-DOCUMENT>0001193125-21-266597-index.html : 20210907
<SEC-HEADER>0001193125-21-266597.hdr.sgml : 20210907
<ACCEPTANCE-DATETIME>20210907160641
ACCESSION NUMBER:		0001193125-21-266597
CONFORMED SUBMISSION TYPE:	F-3/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20210907
DATE AS OF CHANGE:		20210907

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mereo Biopharma Group plc
		CENTRAL INDEX KEY:			0001719714
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-258495
		FILM NUMBER:		211239368

	BUSINESS ADDRESS:	
		STREET 1:		ONE CAVENDISH PLACE
		STREET 2:		FOURTH FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1G0QF
		BUSINESS PHONE:		4403330237300

	MAIL ADDRESS:	
		STREET 1:		ONE CAVENDISH PLACE
		STREET 2:		FOURTH FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1G0QF
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3/A
<SEQUENCE>1
<FILENAME>d159178df3a.htm
<DESCRIPTION>F-3/A
<TEXT>
Document 1 - file: d159178df3a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d159178dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d159178dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d159178dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d159178dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g159178g05a44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g159178g05a44.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g159178g32e42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g159178g32e42.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g159178g77x26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g159178g77x26.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g159178page1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: g159178page1.jpg

</DOCUMENT>
</SEC-DOCUMENT>